Valeria Dina

Dr. Valeria Dina


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
VDValeria Dina
Valeria Dina
Paul Andrei ȚențPaul Andrei Țenț
Paul Andrei Țenț
TMTeodor Andrei Maghiar
Teodor Andrei Maghiar
RBRuxandra Florina Bodog
Ruxandra Florina Bodog
TGTitus Andrei Grecu
Titus Andrei Grecu
ILIoan Lascăr
Ioan Lascăr
Artificial intelligence (AI) is entering surgical planning along a continuum that runs from imaging assistance to near-autonomous plan generation, and facial reconstructive surgery—where outcomes bear directly on identity and social functioning—is among the most sensitive settings for this transition. Existing acceptability research has largely compared AI-supported care with conventional care in binary designs, and Central and Eastern European populations remain underrepresented. This protocol describes a cross-sectional, within-subjects vignette experiment among Romanian adults recruited online (target N = 300 valid responses; minimum analyzable N = 140, raised by a pre-registered rule if the pilot’s inter-scenario correlation falls below the planning assumption). Each participant will read four hypothetical scenarios describing progressively autonomous AI involvement in facial reconstructive surgical planning: imaging assistance, decision support, outcome simulation, and autonomous planning. Participants are randomly allocated to one of the four sequences of a Williams balanced Latin-square design, so that the autonomy level is orthogonal to serial position and to first-order carry-over. After each scenario, they will rate acceptability, trust, and perceived risk (three seven-point Likert items each), responsibility attribution across four loci (surgeon, hospital, AI developer, unavoidable medical uncertainty), perceived AI control and perceived technical sophistication (manipulation checks), and scenario difficulty. Primary analyses are mixed repeated-measures ANOVAs with presentation sequence as a between-subjects factor, orthogonal polynomial (linear, quadratic, cubic) trend contrasts, and Holm-corrected pairwise comparisons, complemented by a position-adjusted linear mixed model; secondary analyses address responsibility migration and concentration, moderation by AI familiarity, and global implementation preferences. A pilot study (N = 50, allocated 1:1 to the ascending and descending sequences) will establish reliability, factor structure, comprehension, manipulation validity, and a first bound on order effects before pre-registration on the Open Science Framework and the start of data collection.

6 November 2026 in Oral
Verified
Journal Article
Open access
PDF file
MBMihai Stefan Benchea
Mihai Stefan Benchea
Paul Andrei ȚențPaul Andrei Țenț
Paul Andrei Țenț
Laurean Ovidiu PopLaurean Ovidiu Pop
Laurean Ovidiu Pop
TMTeodor Andrei Maghiar
Teodor Andrei Maghiar
ANAndreea-Adriana Neamțu
Andreea-Adriana Neamțu
CNCarmen Neamtu
Carmen Neamtu
Background/Objectives: Helicobacter pylori has been detected in the oral cavity as well as the stomach, but the gastric histopathology of periodontal patients with a positive oral urease test is rarely described. We set out to describe it. Methods: In a prospective cross-sectional convenience sample, 71 of 477 patients assessed at 13 referring clinics had clinically recorded periodontal disease, a positive salivary rapid urease test (an operational criterion that is not specific to the organism) and H. pylori identified histologically in a gastric biopsy. Neutrophilic activity, atrophy and intestinal metaplasia were recorded together with smoking, alcohol consumption, proton-pump inhibitor (PPI) use and previous eradication therapy. Only aggregate counts were available, so all comparisons are unadjusted. Results: Intestinal metaplasia was present in 74.6% and non-metaplastic atrophy in 53.5%; both were more frequent in men (metaplasia 93.0% versus 46.4%; odds ratio 13.29, 95% CI 3.57–49.40). Men also differed markedly from women in alcohol consumption (88.4% versus 10.7%) and previous eradication therapy (7.0% versus 85.7%). An exploratory compatibility analysis showed only that neither smoking nor PPI use could, on its own and under the model’s assumptions, account for the male excess; it establishes no causal relationship. Conclusions: In this small, selected cohort, gastric precancerous lesions were frequent. This study has no comparison group, rests on a non-specific oral test, and establishes no association; its findings are descriptive and hypothesis-generating.